(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid

(E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid

Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.


Product Name:                  (E)-3-(1,4-Dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid

Synonyms:                         N/A

CAS Number:                     226916-19-4

Molecular Weight:            210.2292

Molecular Formula:          C11H14O4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(O)/C=C/C1=CCCC2(OCCO2)C1

  • $530.00
  • Ex Tax: $530.00

Available Options